Updated employee announcements, business news, awards, and recognition in the industry today.
People News
Synteract, a CRO providing full-service, Phase I-IV services, has added Cheryl Murphy as Senior Vice President, Clinical Development to its executive team.
Syntactx, a CRO that specializes in medical device, pharmaceutical and genetics clinical trials, announced the appointments of Marlene Barton to the position of Vice President, Department Head, Regulatory Affairs; Chie Iwaishi to the position of Senior Director, Regulatory Affairs; and Darlene Garner to the position of Manager, Regulatory Affairs.
Jane Byram
SCORR Marketing, a full-service marketing and communications firm, has announced the appointment of Jane Byram as media relations director.
Exostar, a provider of cloud-based solutions, announced it has hired Michael Castle to serve as Vice President of Sales and Marketing.
Maxime Stevens
Optimapharm, a full-service CRO, announced that Maxime Stevens is joining their team as Senior Vice President, Business Development.
Business News
Optimapharm, a full-service CRO, is expanding its office network by opening offices in Cambridge, UK.
Recognition
Certara, a company specializing in model-informed drug development, regulatory science, market access and real-world evidence services, announced that Clinical Pharmacology & Therapeutics has published its “Letter to the Editor” together with the EMA’s response. Certara also reported that 95% of novel new drug approvals by the US FDA in the first half of 2018 were supported by their software or services.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Landmark Phase III Trial Shows Keytruda Significantly Improves Event-Free Survival in LA-HNSCC
April 28th 2025Interim KEYNOTE-689 trial data show that perioperative Keytruda significantly lowers the risk of disease progression or recurrence in resectable, locally advanced head and neck squamous cell carcinoma, marking the first major clinical advance for this patient population in more than two decades.